Marshall Wace North America’s Acadia Healthcare ACHC Stock Holding History

Marshall Wace North America’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-21,360	Closed	-$1.34M	–	1392
2021 Q2	$1.34M	Buy	21,360 +13,642	+177%	+$855K	0.01%	932
2021 Q1	$441K	Buy	+7,718	New	+$418K	﹤0.01%	1234
2020 Q4	–	Sell	-8,267	Closed	-$244K	–	1275
2020 Q3	$244K	Buy	+8,267	New	+$240K	﹤0.01%	1104
2020 Q1	–	Sell	-80,276	Closed	-$2.67M	–	1180
2019 Q4	$2.67M	Buy	+80,276	New	+$2.52M	0.01%	514
2019 Q2	–	Sell	-45,803	Closed	-$1.34M	–	1103
2019 Q1	$1.34M	Buy	+45,803	New	+$1.3M	0.01%	614
2017 Q2	–	Sell	-425,462	Closed	-$18.7M	–	1271
2017 Q1	$18.7M	Buy	+425,462	New	+$17.3M	0.15%	183

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Marshall Wace North America's ACHC Position: Q3 2021 in Review

Marshall Wace North America sold out of Acadia Healthcare (ACHC) in Q3 2021, closing a stake of 21,360 shares — an estimated $1.34M sold.

Marshall Wace North America first reported a position in ACHC in Q1 2017 and held it in 6 quarters. The position peaked at $18.7M in Q1 2017. 293 funds tracked by Wall St. Rank hold ACHC as of Q3 2021.

Marshall Wace North America reported no remaining Acadia Healthcare position as of Q3 2021 after selling out during the quarter.
Marshall Wace North America sold 21,360 Acadia Healthcare shares in Q3 2021, an estimated $1.34M.
Marshall Wace North America first reported a position in Acadia Healthcare in Q1 2017 and held it in 6 quarters.
Marshall Wace North America's Acadia Healthcare position peaked at $18.7M in Q1 2017.
293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.